Skip to main content
Premium Trial:

Request an Annual Quote

Boston U Lung Researchers Seek New Cancer Test With Affy Chips

NEW YORK, Jan. 22-Boston University Medical Center pulmonary researchers will work with Affymetrix to develop a new, less invasive screen for lung cancer, the university and the company said jointly today.

 

BUMC's Jerome Brody and Avrum Spira are working on a sample collection method that would involve scraping the airways, eliminating the need for deep lung biopsies.

 

The two researchers will study these samples with Affymetrix's microarrays, looking for gene expression changes that can be used to detect and monitor cancer and guide appropriate treatment and prognosis.

 

Lung cancer is difficult to diagnose, and kills more than 150,000 each year in the United States.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.